89 related articles for article (PubMed ID: 10208931)
21. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC
Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
[TBL] [Abstract][Full Text] [Related]
22. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
Qiao W; Xie P; Cai B; Li L
Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
[TBL] [Abstract][Full Text] [Related]
23. Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation.
Mello IM; Thumann C; Schvoerer E; Soulier E; Pinho JR; Silvestre DA; Queiroz AT; Wolf P; Baumert TF; Keller FS; Pereira CA
J Viral Hepat; 2009 Oct; 16(10):732-7. PubMed ID: 19486468
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C epitopes from phage-displayed cDNA libraries and improved diagnosis with a chimeric antigen.
Pereboeva LA; Pereboev AV; Wang LF; Morris GE
J Med Virol; 2000 Feb; 60(2):144-51. PubMed ID: 10596013
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of NS5a strong antigenic regions of hepatitis C virus in E.coli and detection of their antigenicity.
Dou XG; Feng GH; Shi LL; Fields H
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):383-7. PubMed ID: 14607711
[TBL] [Abstract][Full Text] [Related]
27. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C in northern Estonia.
Tallo T; Lappalainen M; Tefanova V; Priimägi I
Acta Virol; 2000; 44(3):175-8. PubMed ID: 11155361
[TBL] [Abstract][Full Text] [Related]
28. Characterization of monoclonal antibodies and epitope mapping of the NS4 protein of hepatitis C virus.
Masalova OV; Lakina EI; Abdulmedzhidova AG; Atanadze SN; Semiletov YA; Shkurko TV; Burkov AN; Ulanova TI; Pimenov VK; Novikov VV; Khudyakov YE; Fields H; Kushch AA
Immunol Lett; 2002 Oct; 83(3):187-96. PubMed ID: 12095709
[TBL] [Abstract][Full Text] [Related]
29. Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes.
Toyoda H; Fukuda Y; Hayakawa T; Kumada T; Nakano S; Takamatsu J; Saito H
Am J Gastroenterol; 1999 Aug; 94(8):2230-6. PubMed ID: 10445555
[TBL] [Abstract][Full Text] [Related]
30. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins.
Sarobe P; Lasarte JJ; García N; Civeira MP; Borrás-Cuesta F; Prieto J
J Viral Hepat; 2006 Jan; 13(1):47-55. PubMed ID: 16364082
[TBL] [Abstract][Full Text] [Related]
31. [Hepatitis C virus].
Querenghi F; Zoulim F
Rev Prat; 2000 May; 50(10):1060-5. PubMed ID: 10905089
[TBL] [Abstract][Full Text] [Related]
32. Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse.
Eisenbach C; Freyse A; Lupu CM; Weigand K; Ernst E; Hoyler B; Stremmel W; Bugert JJ; Encke J
Vaccine; 2006 Jun; 24(24):5140-8. PubMed ID: 16713033
[TBL] [Abstract][Full Text] [Related]
33. [Cloning and sequence analysis of E1, E2/NS1 region of genotype 2a hepatitis C virus genome].
Feng B; Wu WY; Chen HS; Chen Y; Cong X; Wei L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):28-30. PubMed ID: 12870013
[TBL] [Abstract][Full Text] [Related]
34. Memory T-cell-mediated immune responses specific to an alternative core protein in hepatitis C virus infection.
Bain C; Parroche P; Lavergne JP; Duverger B; Vieux C; Dubois V; Komurian-Pradel F; Trépo C; Gebuhrer L; Paranhos-Baccala G; Penin F; Inchauspé G
J Virol; 2004 Oct; 78(19):10460-9. PubMed ID: 15367612
[TBL] [Abstract][Full Text] [Related]
35. Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV.
Akhavan S; Schnuriger A; Lebray P; Benhamou Y; Poynard T; Thibault V
J Infect Dis; 2009 Aug; 200(4):524-7. PubMed ID: 19604114
[TBL] [Abstract][Full Text] [Related]
36. Artificial neural network for prediction of antigenic activity for a major conformational epitope in the hepatitis C virus NS3 protein.
Lara J; Wohlhueter RM; Dimitrova Z; Khudyakov YE
Bioinformatics; 2008 Sep; 24(17):1858-64. PubMed ID: 18628290
[TBL] [Abstract][Full Text] [Related]
37. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
38. The hypervariable region 1 protein of hepatitis C virus broadly reactive with sera of patients with chronic hepatitis C has a similar amino acid sequence with the consensus sequence.
Watanabe K; Yoshioka K; Ito H; Ishigami M; Takagi K; Utsunomiya S; Kobayashi M; Kishimoto H; Yano M; Kakumu S
Virology; 1999 Nov; 264(1):153-8. PubMed ID: 10544140
[TBL] [Abstract][Full Text] [Related]
39. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
40. Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6.
Bhattacherjee V; Prescott LE; Pike I; Rodgers B; Bell H; El-Zayadi AR; Kew MC; Conradie J; Lin CK; Marsden H
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1737-48. PubMed ID: 9049379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
